Trademark: 97920385
Word
A
Status
Pending
Status Code
641
Status Date
Friday, January 26, 2024
Serial Number
97920385
Mark Type
3000
Filing Date
Thursday, May 4, 2023

Trademark Owner History

Classifications
5 Pharmaceutical preparations, such as, drug delivery agents in the nature of lipid nanoparticle carriers that facilitate delivery of pharmaceutical preparations and nucleic acid therapeutics; pharmaceutical preparations comprised of nucleic acids, including messenger RNA, and lipid nanoparticles; pharmaceutical preparations comprised of lipid nanoparticles; pharmaceutical preparations, such as, vaccines for human use; pharmaceutical preparations for gene silencing, for gene editing, for antibody therapeutics, for protein replacement therapeutics, and for nucleic acid therapeutics
1 Lipids, lipid nanoparticles, lipid formulations, and nucleic acids, including messenger RNA, for scientific purposes, research purposes, or laboratory use
45 Regulatory compliance consultancy services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid nanoparticles, nucleic acid, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology
42 Research, development, and evaluation services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology; synthetic chemistry services, such as, design, synthesis, analysis, evaluation, and biophysical characterization of lipids, lipid formulations, and lipid nanoparticles; preclinical study services, such as, conducting pharmacodynamic and pharmacokinetic studies, safety and tolerability studies regarding clinical pathology and histopathology, immune response characterization studies, and bioanalytical services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, and nucleic acid therapeutics; clinical research services, such as, chemical molecular analysis, product optimization, and clinical trial services to pharmaceutical industries; research and development of new formulation products for others; research and development of new pharmaceuticals, medical therapies, vaccines, gene therapies, drug delivery agents, and nucleic acid therapeutics for others; project management services for research and development programs in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology; consultancy services in the fields of pharmaceuticals, medical therapies, immunology, vaccines, biotechnology, nanotechnology, gene therapy, lipids, lipid formulations, lipid nanoparticles, nucleic acids, including messenger RNA, drug delivery agents, nucleic acid therapeutics, and synthetic chemistry process technology
The mark consists of a circle with an "A" inside, with the horizontal line of the "A" having been replaced by a dot.
ACUITAS
Color is not claimed as a feature of the mark.

Trademark Events
Jan 26, 2024
Notification Of Non-Final Action E-Mailed
Jan 26, 2024
Non-Final Action E-Mailed
Jan 26, 2024
Non-Final Action Written
Jan 26, 2024
Assigned To Examiner
Jun 3, 2023
Notice Of Design Search Code E-Mailed
Jun 2, 2023
New Application Office Supplied Data Entered
May 8, 2023
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24